Exelixis (EXEL) Tops Q1 EPS by 6c, Beat on Revenues

Exelixis (NASDAQ: EXEL) reported Q1 EPS of $0.05, $0.06 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $80.9 million versus the consensus estimate of $65.23 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Burry doubles down on Nebius short after stock surges 34% on earnings
• Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c